— Know what they know.
Not Investment Advice

ELYM NASDAQ

Eliem Therapeutics, Inc.
1W: -14.4% 1M: -17.5% 3M: -49.5% 1Y: +55.7% 3Y: -77.7%
$5.11
Last traded 2024-10-28 — delisted
NASDAQ · Healthcare · Biotechnology · $342.7M mcap · 26M float · 1.94% daily turnover

No ESG data available for ELYM

ESG scores are derived from SEC filings (10-K, 10-Q) and may not be available for all companies.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms